Bio-production of vindoline and catharanthine by recombinant yeast cell factories

The tropical plant Madagascar periwinkle (Catharanthus roseus) is a natural source of anticancer monoterpene indole alkaloids (MIA), such as vinblastine and vincristine, two molecules of major interest and therapeutic values. The MIA biosynthetic pathway in C. roseus is described in the literature as the most complex pathway in all living organisms and shows, in planta, an outstanding compartmentation at both cellular and subcellular levels. Our approach aimed to producing vindoline and catharanthine, two precursors of vinblastine and vincristine, in yeast cell factories. In particular, we developed and optimized yeast cell factories efficiently converting tabersonine to vindoline. First, fine-tuning of heterologous gene copies restrained side metabolites synthesis towards vindoline production. Tabersonine to vindoline bioconversion was further enhanced through a rational medium optimization (pH, composition) and a sequential feeding strategy. Finally, a vindoline titer of 266 mg/L (88% yield) was reached in an optimized fed-batch bioreactor. This precursor-directed synthesis of vindoline thus paves the way towards a future industrial bioproduction through the valorization of abundant tabersonine resources.